Loblaw 3Q Profit Rises on PC Financial Sale Gain, Pharmacy Demand
By Adriano Marchese
Loblaw posted higher third-quarter profit, boosted by a gain from the sale of PC Financial and steady pharmacy growth which drove sales higher.
The Canadian grocery retailer posted on Thursday a rise in net income to 1.19 billion Canadian dollars ($830.5 million), or C$1.03 a share, up from C$794 million, or C$0.66 a share, in the comparable quarter a year ago.
The company benefited from the sale of its financial arm, PC Financial.
Adjusted earnings, which excludes one-off items and exceptional costs, were C$0.74 a share, in-line with analyst expectations, according to FactSet.
Sales rose to C$19.86 billion, from C$19.16 billion, but came in just shy of the C$19.87 billion expected by analysts.
The company's food segment saw a 2.8% growth in sales, while its pharmacy segment rose 5.7%. Ecommerce sales rose 17% in the quarter.
Food retail same-store sales were up 0.6% in the quarter, while its pharmacy segment saw a rise of 4.8%.
Write to Adriano Marchese at adriano.marchese@wsj.com
(END) Dow Jones Newswires
November 19, 2026 07:15 ET (12:15 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular

5 Stocks to Buy After Earnings

The 10 Best Dividend Stocks

7 Undervalued Stocks That Crushed Earnings

The Best Balanced Funds and ETFs

